Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan. | Ther Clin Risk Manag;6: 359-66, 2010 Sep 07. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan.

Schuuring, Mark J; Vis, Jeroen C; Duffels, Marielle G; Bouma, Berto J; Mulder, Barbara Jm.

Affiliation

Schuuring MJ; Department of Cardiology, Academic Medical Centre, Amsterdam, The Netherlands;

Ther Clin Risk Manag ; 6: 359-66, 2010 Sep 07.

Article in En | MEDLINE | ID: mdl-20856682

Key words

bosentan; congenital heart disease; endothelin-1 receptor antagonist; pulmonary arterial hypertension

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies Language: En Journal: Ther Clin Risk Manag Year: 2010 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies Language: En Journal: Ther Clin Risk Manag Year: 2010 Type: Article